What to Know · May 26, 2026 · 5 min

Laser for Cherry Angiomas: How Dermatologists Remove These Common Red Spots

A clinical overview of laser treatment options, candidate selection, recovery expectations, and realistic outcomes for cherry angiomas.

Laser for cherry angiomas has become a standard treatment option in dermatology practices over the past two decades. Cherry angiomas are benign vascular lesions, appearing as small bright-red or dark-red papules typically on the trunk and extremities. While harmless and purely cosmetic in nature, many patients seek removal for appearance reasons. Understanding how laser treatment works, who qualifies as a candidate, and what realistic outcomes look like can help patients make informed decisions about their care.

Cherry angiomas are composed of dilated capillaries and endothelial cells clustered just below the skin surface. The lesions become more common with age, appearing in roughly 75 percent of individuals over 75 years old. A laser targets these vascular lesions by emitting wavelengths that are selectively absorbed by hemoglobin, the oxygen-carrying protein in red blood cells. When the laser energy is absorbed, it generates heat that causes the blood vessel walls to coagulate and collapse. The body then gradually reabsorbs the damaged tissue over subsequent weeks and months.

Several laser types have demonstrated effectiveness for cherry angioma removal. The 585-nanometer pulsed dye laser (PDL) is considered the gold standard and remains the most widely used. It directly targets oxyhemoglobin and produces minimal collateral thermal damage to surrounding skin. The 532-nanometer potassium-titanyl-phosphate laser (KTP) operates at a shorter visible wavelength and offers another effective option, though it carries a slightly higher risk of post-inflammatory hyperpigmentation in darker skin types. The 1064-nanometer neodymium-doped yttrium aluminum garnet laser (Nd:YAG) penetrates deeper and is often reserved for larger or deeper angiomas, but also carries greater risk of scarring and textural changes. For patients with darker skin tones (Fitzpatrick types IV through VI), PDL and longer-wavelength lasers like Nd:YAG are generally preferred because they carry lower risk of post-inflammatory hyperpigmentation compared to the KTP.

Candidacy for laser treatment is straightforward for most patients. The lesions must be clinically diagnosed as cherry angiomas rather than other vascular conditions like port-wine stains or hemangiomas, which may require different treatment approaches. Patients should have realistic expectations about results and understand that multiple treatment sessions are often needed. Individuals with active sun exposure, recent tanning, or certain medications that increase photosensitivity may be advised to reschedule. Pregnancy is typically a relative contraindication, though safety data on lasers in pregnancy remains limited. Patients taking anticoagulants or with bleeding disorders should inform their provider, as these conditions may increase bruising risk.

During treatment, the clinician marks the lesions and applies protective eyewear. Most modern systems use dynamic cooling devices that spray cryogen onto the skin immediately before each laser pulse, reducing discomfort and minimizing blistering. The procedure itself typically takes 10 to 30 minutes depending on the number and size of lesions. Patients report a sensation of mild snapping or stinging, often described as rubber-band snaps against the skin. Topical anesthesia or local infiltration may be used for patients with lower pain tolerance. For related context, see our note on How to choose the right laser treatment for your concern.

Immediate post-treatment appearance includes purpura (purple discoloration) that typically persists for 7 to 14 days. Some patients experience mild crusting or edema. Most lesions fade significantly after a single treatment, though residual color often remains for 4 to 6 weeks as hemosiderin (iron from broken-down blood) is resorbed. Complete clearance frequently requires two to four sessions spaced 4 to 8 weeks apart. Patients should avoid direct sun exposure, use high-SPF sunscreen, and avoid irritating products during the healing window. Complications are rare but may include temporary hyperpigmentation or hypopigmentation, particularly in darker skin types. Scarring or textural change is uncommon with PDL but increases with higher-energy Nd:YAG treatments.

Cost varies by geographic region, practice setting, and number of lesions treated. Individual cherry angioma removal typically ranges from 150 to 500 dollars per treatment session. Patients with numerous lesions may pay 500 to 2000 dollars per session, depending on the extent of the area treated and the specific technology used. Many insurance plans do not cover laser removal of cherry angiomas because the procedure is cosmetic, though some may cover treatment if the lesion bleeds or causes functional symptoms.

Expectations for final results are generally positive. Most patients achieve 75 to 95 percent clearance or significant fading of treated lesions. Some lesions may recur over months to years, reflecting the chronic nature of the underlying vascular tendency. Treatment success depends on lesion depth, color intensity, and individual healing response. Discussing realistic outcomes with a dermatologist before treatment helps align patient expectations with achievable results.

Related reading: Ablative vs. non-ablative laser resurfacing, Picosecond vs Q-switched laser: Which technology removes pigment better?.